Johannes Levin works as professor for Clinical Neurodegeneration at the Department of Neurology, Ludwig-Maximilians-University Munich and is deputy leader for clinical research at the German Center for Neurodegenerative Diseases (DZNE), site Munich. He has been working in the field of neurodegeneration for 20 years focusing clinically on movement disorders and genetic forms of dementia. The principal research focus is the molecular pathogenesis of neurodegenerative diseases with emphasis on protein aggregation, biomarker development for neurodegenerative diseases and therapy development targeting protein aggregation. Based on this background he joined MODAG GmbH as part-time CMO where he continues his academic work on the oligomer modulator anle138b in an industry setting, where the compound is currently at early stages of clinical development. He has a proven track record for coordinating academic research studies and is principal investigator of the largest interventional trial in Multiple System Atrophy in Germany involving 92 patients at 12 centers (PROMESA trial) with long standing experience in conducting industry sponsored trials. Moreover, he is principal investigator in several national studies and in international cohort studies such as the Dominantly Inherited Alzheimer’s Network (DIAN) and the Genetic Fronto-temporal dementia Initiative (GENFI).
HEADQUARTERS & ADMINISTRATION
53 Rothschild Boulevard
PO Box 68
Tel Aviv, 6100001, Israel
Tel: +972-3-5666166
Fax: +972-3-5666177
office@comtecmed.com
COMTEC SPAIN
Bailen, 95 – 97
pral.1.a – 08009
Barcelona, Spain
Tel: +34-932081145
Fax: +34-934579291
spain-office@comtecmed.com
COMTEC CHINA
Suite 405, Universal Center Building
175 Xiang Yang Road South
Shanghai 200031, China
Tel: +86-21-54660460
Fax: +86-21-54660450
china-office@comtecmed.com
COMTEC USA
415 South Street
POB #3627
Waltham, MA 02453-2700
Tel: +1-914-312-5407
Fax: 972-3-566-6177
usa-office@comtecint.com